Download Citation
Article Source:
Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations
The PLOS One Editors
(2026)
Retraction: Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations.
PLOS ONE 21(5): e0348537.
https://doi.org/10.1371/journal.pone.0348537